
It’s Time for Broadened Screening for Asymptomatic Patients at Risk for Barrett’s Esophagus and Esophageal Cancer
Chronic GERD is no longer a prerequisite to screen for Barrett’s esophagus—other risk factors may prove to be more valuable.
Chronic GERD is no longer a prerequisite to screen for Barrett’s esophagus—other risk factors may prove to be more valuable.
Recognizing risks is the first step to identifying disease.
The increase in 45-to-64-year-olds is important context for identifying who is at highest risk.
Kenneth Wang, MD, reviewed recent innovations in cryotherapy and tissue resection that are improving outcomes for patients with Barrett’s esophagus, especially those who have failed standard therapy.
Jacob E. Kurlander, MD, MS, of the Veterans Affairs (VA) Center for Clinical Management Research and Michigan Medicine shared data on the largest PPI deprescribing intervention in Veterans, showing that these programs help reduce PPI prescribing, without increasing adverse events.
Read a brief summary of the abstract “Risk of cancer with use of ranitidine: Results of a cohort study of 65 million US adults.”
Listen to discussant Daniela Molena, MD, review the best abstracts presented at DDW 2019 with the Best of SSAT podcast, now available for downloads.
Gain access to hundreds of hours of recorded sessions from Digestive Disease Week® (DDW) 2019 and earn CME credits with DDW On Demand.
SSAT’s educational programming continues Monday with more than two dozen sessions, including a Clinical Ward Rounds session and two GI Surgery Debates. Vic Velanovich, MD, shares more.
In this DDW News video, Michael G. House, MD, discusses present and future applications of computer-assisted minimally invasive surgical platforms.